Hospital

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how the COVID-19 pandemic is going to impact cancer mortality.

MET exon 14 skipping alterations occur in approximately 3% of adenocarcinomas and approximately 2% in other lung neoplasms, making them attractive potential targets for lung cancer treatment.

According to the CDC, the ability to evade natural or vaccine-induced immunity could be the most concerning consequence of emerging variants.

Rather than having an intrinsically lower risk of severe COVID-19, the patients in the study may have adhered more strictly to social distancing guidelines compared to the general population.

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how screening can help reduce cancer deaths.

The study authors found marked improvements in rates of hazardous prescribing over the 12-month study period and the success of the intervention was sustained at the end.

Study shows the greatest hesitancy in seeking emergency medical services among families living in under-resourced communities, which highlight health inequities that already exist during the pandemic.

The drug is a novel, nonopioid, sustained-release local analgesic indicated for use as postsurgical analgesia for up to 72 hours.

The participating national pharmacy partners and independent pharmacy networks represent more than 40,000 pharmacy locations and is a key component of the administration’s national strategy to expand access to vaccines.

Three international cardiovascular outcomes trials are currently examining the cardioprotective effects of different influenza vaccine formulations.

Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers about the effect of coronavirus disease 2019 (COVID-19) on cancer clinical trials.

The level of protection for the single-dose COVID-19 vaccine was 72% in the United States compared to 57% in South Africa at 28 days post-vaccination, suggesting lower efficacy against the emerging South African variant.

With increasing rates of diabetes and its risk factors, the researchers emphasized the urgency of developing effective interventions.

In addition to stress and burnout caused by the COVID-19 pandemic, pharmacists face threats of physical violence and online doxxing.

Interventions to reduce suffering, restore connections with others, and maintain safety are essential, and normalizing conversations about suicidal ideation and suicide itself is important.

Studies have shown that patients with Parkinson disease admitted to the hospital experience longer hospital stays and increased mortality than age matched control groups.

In addition to communicating about COVID-19 vaccine eligibility, uses for online portals include requesting prescription refills, seeking advice on health concerns, and scheduling appointments.

Study finds that death was significantly less likely for type 2 diabetes subjects taking metformin, compared to those not taking metformin.

In successive surveys over the past several months, an increasing number of pharmacists said they plan to be immunized, plan to manage the logistics of handling the vaccine, and will administer it to patients.

The perception of creativity has been limited merely to art and innovation, neglecting one of the main sectors that strives for this: education.

Obstacles to cancer screenings for low-income patients can include lack of transportation and an inability to take time off of work.

New treatment approach is designed to treat retracted blood clots, which form over extended periods of time and are especially dense.

Macrophages could be critical treatment targets because they could be infected by SARS-CoV-2 and can contribute to spreading the infection through the lung.

Crizotinib is the first biomarker-driven therapy for relapsed or refractory anaplastic large cell lymphoma in children and young adults.

Recent surveys indicate that the proportion of the US population willing to be vaccinated for COVID-19 has fluctuated from 72% in May to 51% in September 2020.

The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.

One of the main challenges with the distribution process is that each state has its own jurisdictional plan, which can create some confusion.

Moderna, Inc has also announced temporary authorization of its COVID-19 vaccine in Switzerland.